Blog

In the relentless fight against cancer, immunotherapy has emerged as a beacon of hope, harnessing the body's own defenses to combat malignant cells. Yet, predicting which patients will respond to these groundbreaking treatments remains a critical challenge. Recent scientific breakthroughs are now pointing towards an unexpected ally in this quest: IgG1 plasma cells, revealing their potential as a powerful new biomarker to forecast the success of cancer immunotherapy. Introduction Immunotherapy, particularly immune checkpoint blockade (ICB), has revolutionized cancer treatment, offering durable responses for many patients. However, a significant portion of individuals do not benefit, undersco …

Breakthrough Discovery: Epstein-Barr Virus Identified as Primary Trigger for Lupus A groundbreaking study published in November 2025 has provided the most definitive evidence to date that the common Epstein-Barr virus (EBV) is a primary trigger for systemic lupus erythematosus (SLE), a complex and debilitating autoimmune disease. The research, led by a team at Stanford University, uncovers the precise cellular mechanisms by which this nearly ubiquitous virus can cause the immune system to turn against the body's own tissues, a finding that could revolutionize the diagnosis and treatment of lupus and other autoimmune disorders. For decades, scientists have suspected a link between EBV and lu …